Stock Take
Stock Take

Oct 1, 2026 · 30 min

Australia’s growth model faces a test as investors reassess Sonic

Stock Take: Is the Economic Model Starting to Crack?

The episode connects Australia’s productivity, housing and policy challenges to portfolio choices, then tests those concerns against Sonic Healthcare’s investment case.

3 key takeaways
  1. 1Australia’s reliance on housing, China and regulation raises questions about productivity and the durability of its growth model.
  2. 2Macroeconomic weakness does not automatically imply lower stock valuations, forcing investors to separate economic outlook from company fundamentals.
  3. 3Sonic Healthcare looks attractively valued, but government funding, technology and changing healthcare demand remain material risks.

Don't miss

The discussion reveals that Sonic Healthcare’s sharp fall in short interest reflected hedge-fund positioning around a potential MSCI Australia index change, not necessarily improved fundamentals.

The brief

Gaurav Sodhi, Nick Cummings and Graham Witcomb examine whether Australia’s traditional growth model is losing momentum, citing weak productivity, housing leverage, regulation, taxation and dependence on China.

The hosts debate how national decline and policy choices should affect portfolios, while stressing that economic conditions and stock-market valuations can move in opposite directions.

The central investment question is whether concerns about Australia justify greater overseas exposure or whether lower valuations could create opportunities despite structural weaknesses.

Graham Witcomb presents Sonic Healthcare as potentially undervalued, pointing to organic growth, scale, acquisitions and possible corporate activity against market scepticism.

The Sonic case turns on government-funded pathology, fewer GP visits, artificial intelligence and changing diagnostics, with test volumes and efficiency gains offering a counterweight.

Nick Cummings explains that Sonic’s falling short interest reflected index-positioning by hedge funds, a reminder that short sellers’ motives may not reflect fundamentals.

What was said on this episode

23 statements · 9 positive · 13 negative · 1 neutral

  1. Gaurav Sodhion Australian economyNegative1:30

    Australia’s current economic difficulties will differ from previous crises.

    “I think this one is going to be different.”

    Listen at 1:30

  2. Nick Cummingson Australia’s growth modelNegative1:56

    Australia’s China-export, population-growth, and housing-leverage model is weakening.

    “our old growth model of export stuff to China, a little bit of population growth and housing leverage, I do think is starting to wobble.”

    Listen at 1:56

  3. Nick Cummingson Australian productivityNegative2:45

    Australia ranks near the OECD bottom on productivity.

    “We rank near the bottom of the OECD over the last couple of years.”

    Listen at 2:45

  4. Nick Cummingson Australian innovationNegative3:23

    Australia is producing relatively few new innovative companies.

    “We don't have a lot of new innovative companies coming through.”

    Listen at 3:23

  5. Gaurav Sodhion Cheap energy accessPositive5:11

    Access to cheap energy is common among rapidly growing countries.

    “One thing common with all countries that grow quickly is access to cheap energy”

    Listen at 5:11

  6. Gaurav Sodhion Australian government tax and spendingNegative9:59

    Australian government taxation and spending are excessive.

    “government tax and spending is just out of control”

    Listen at 9:59

  7. Gaurav Sodhion Australian inflation vulnerabilityNegative10:46

    Australia is currently unusually vulnerable to inflation.

    “Australia is uniquely prone to inflation at this point”

    Listen at 10:46

  8. Gaurav Sodhion Government-funded and discretionary-spending businessesNegative11:31

    Investors should reconsider businesses dependent on government funding or discretionary spending.

    “Probably I'm thinking twice about it.”

    Listen at 11:31

  9. Nick Cummingson Business valuationsNegative12:40

    Persistent economic problems can eventually reduce business valuations.

    “some of the problems we have brought up can over time lead to lower valuations”

    Listen at 12:40

  10. Nick Cummingson London Stock Exchange valuationNegative13:52

    London Stock Exchange trades at a lower multiple than comparable exchanges.

    “it trades at a far lower multiple than the ASX or an equivalent exchange in America.”

    Listen at 13:52

  11. Gaurav Sodhion Australian economyNegative14:56

    Australia could experience prolonged economic stagnation.

    “We could be in for a long drawn-out period of nothing, of stagnation.”

    Listen at 14:56

  12. Gaurav Sodhion Equity valuesNegative15:02

    Prolonged economic stagnation would damage equity values.

    “that is really destructive for equity values.”

    Listen at 15:02

  13. Nick Cummingson Australian policy changeNegative16:09

    Major Australian policy change may require an economic crisis.

    “to get the change we're talking about, I honestly think you only see it if we get an economic crisis.”

    Listen at 16:09

  14. Gaurav Sodhion Gaurav Sodhi’s portfolioNeutral17:04

    Gaurav is slowing investment decisions and reducing portfolio concentration.

    “acting a little slower and, uh, and for me anyway, um, reducing my concentration.”

    Listen at 17:04

  15. Sonic Healthcare is currently undervalued.

    “I think that it's undervalued at the moment”

    Listen at 18:34

  16. Graham Witcombon Sonic Healthcare organic growthPositive19:12

    Sonic’s organic growth is near its highest level in two decades.

    “For Sonic, that is kind of almost at the highest that it's been in 20 years.”

    Listen at 19:12

  17. Graham Witcombon Pathology industryPositive19:18

    The underlying pathology industry is performing strongly across several markets.

    “the underlying pathology industry is doing very, very well”

    Listen at 19:18

  18. Sonic Healthcare may rebound during the current year.

    “maybe this is the year Sonic rebounds”

    Listen at 22:16

  19. Graham Witcombon Pathology testsPositive24:26

    The number and variety of available pathology tests continue expanding.

    “there are more tests than ever and more being invented constantly.”

    Listen at 24:26

  20. Sonic Healthcare would benefit from expanding pathology-test availability.

    “Sonic would benefit from that too.”

    Listen at 24:42

  21. Graham Witcombon Sonic Healthcare efficiencyPositive25:51

    Sonic’s efficiency has helped contain healthcare-budget growth.

    “Sonic has been a big part of why the, the healthcare budget hasn't exploded even more”

    Listen at 25:51

  22. Sonic Healthcare will not become increasingly efficient.

    “Sonic won't become increasingly efficient.”

    Listen at 26:13

  23. Graham Witcombon Heavily shorted stocksPositive28:01

    Investors should not automatically panic over heavily shorted stocks.

    “you shouldn't necessarily freak out when you see stocks that are being overly shorted”

    Listen at 28:01

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

Australia’s growth model faces a test as investors reassess Sonic | PodLume